BWAY > BrainsWay Received FDA Clearance for Smoking-Cessation Aid 7:13 am ET August 24, 2020 (Dow Jones) Print By Dave Sebastian
BrainsWay Ltd. said the Food and Drug Administration has granted a clearance for its deep transcranial magnetic simulation system as an aid in short-term smoking cessation in adults.
The company on Monday said it plans to do a controlled U.S. market release in early 2021 for the system.
BrainsWay said it tested the system on 262 eligible subjects, assessing their four-week continuous quit rate.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.